PATIENT ENGAGEMENT: DRIVING PATIENT ADVOCACY TO INFORM PATIENT CENTRIC DEVELOPMENT
11:00 – CHAIR INTRODUCTION
Chair: Karin Blumer, Director Global Patient Engagement, Novartis
11:05 – CASE STUDY: STRATEGIC APPROACH TO INTERNATIONAL HARMONISATION OF GENE THERAPY PRODUCTS
Speaker: Katherine Donigan, Senior Director Science & Regulatory, Biotechnology Innovation Organisation (BIO)
11:20 – CASE STUDY: THE TRUSTED BROKER: INVOLVING AND ENGAGING PATIENTS AND ADVOCATES IN POLICY MAKING
Speaker: Anna Dickinson, Senior Policy Analyst Lifesciences, Public Policy Projects
11:35 – CASE STUDY: THE VALUE OF EARLY PATIENT ENGAGEMENT TO BUILD CREDIBILITY & SUPPORT FOR CLINICAL DEVELOPMENT OF A FIRST IN CLASS CELL THERAPY FOR HEARING LOSS
Speaker: Simon Chandler, CEO, Rinri Therapeutics
11:35 – CASE STUDY: PATIENT ENGAGEMENT AND CAR-T BUILDING A PLANE WHILST FLYING IT
Speaker: Karin Blumer, Director Global Patient Engagement, Novartis
12:05 – PANEL DISCUSSION
Speakers:
Anna Dickinson, Senior Policy Analyst Lifesciences, Public Policy Projects
Simon Chandler, CEO, Rinri Therapeutics
Katherine Donigan, Senior Director Science & Regulatory, Biotechnology Innovation Organisation (BIO)
Speakers
